HER2阴性转移性乳腺癌病人二线治疗的有效性和安全性评估:RIBBON-2
HER2음성전이성유선암병인이선치료적유효성화안전성평고:RIBBON-2
RIBBON-2:Evaluating the Efficacy and Safety of Bevacizumab in Combination with Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
  • 万方数据
    循证医学 순증의학
    THE JOURNAL OF EVIDENCE-BASED MEDICINE
    2012年 3期 153-156 ,共4页

    王晓稼%钱学珂

    왕효가%전학가

    乳腺肿瘤%临床试验,Ⅲ期%贝伐单抗%转移性乳腺癌%人表皮生长因子受体-2 乳腺腫瘤%臨床試驗,Ⅲ期%貝伐單抗%轉移性乳腺癌%人錶皮生長因子受體-2
    유선종류%림상시험,Ⅲ기%패벌단항%전이성유선암%인표피생장인자수체-2


    원문보기 원문다운로드 사이트로이동
저자의 최근 논문